Pfizer Payout Strains: Income Investors Face Hard Truth
Pfizer paid more in dividends than its free cash flow in 2025, a warning sign for income investors facing hard realit...
Allocating to a wide market index fund for retirement aims to spread risk across the market, supporting steady growth while keeping fees reasonable.
28,235 articlesPfizer paid more in dividends than its free cash flow in 2025, a warning sign for income investors facing hard realit...
As interest rates hover higher, retirees seek dependable income. Philip Morris International stands out as a dividend...
As markets swing in June 2026, retirees with over million are shifting from pure cash to a five-year ladder that blen...
As SpaceX eyes an IPO, investors wonder how Starlink's trajectory could change. This guide breaks down potential futu...
As 2026 unfolds, AT&T and Verizon compete for income and growth. This analysis weighs dividend safety, leverage, and ...
Curious if you can own SpaceX stock before its IPO through Hyperliquid? This guide explains why that pre-IPO thrill o...
A high-stakes earnings year and a single insider trade create a nuanced picture for ANI Pharmaceuticals. This guide b...
The 2026 Social Security cost-of-living adjustment adds dollars to checks, yet rising Medicare premiums and IRMAA sur...
A reserves-and-resources update put Coeur Mining back in focus, with millions of ounces of gold on the books and a pr...
Air-taxi darlings Joby, Archer, and EHang have fallen sharply in 2026 as cert timelines and cash burn loom large. Inv...
Last week Plug Power stock beat the market by about 7 percent, signaling momentum in hydrogen and clean energy. This ...
Lululemon faces renewed headwinds as leadership shifts and governance questions surface. This comprehensive look brea...